SENS
SenseonicsFNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
Current thesis
The best post-earnings bull argument is that Q1 showed real commercialization traction: revenue nearly doubled year over year, U.S. revenue more than doubled, gross margin expanded to 59%, and FY2026 revenue guidance was raised [#8-K-2026-05-07].
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Commercial transition risk remains high as Senseonics takes Eversense sales and marketing in-house in Europe and absorbs the U.S. model shift.
Momentum
18
Value
36
Sentiment
33
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.60 · Bull $7.20 · Bear $4.10
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $19.00
Why
Momentum18 · Δ7d +6.8
Value36 · Δ7d -0.0
Sentiment33 · Δ7d -5.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
18
34% active weight
Current posture
7d trendImproving
Δ7d
+6.8
Δ21d
+11.4
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
33
33% active weight
Current posture
7d trendSoftening
Δ7d
-5.0
Δ21d
-9.3
Why this grade
Composite grade F. Momentum 18.0 / Value 36.3 / Sentiment 33.2
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$358.63M
Beta
0.99
Shares Out
40.86M
P/E (TTM) · Derived
-5.3
P/S (TTM)
8.47
P/FCF (TTM) · Derived
-6.05
Rev YoY
+89.9%
EPS YoY
+43.7%
Gross Margin
+41.1%
Op Margin
-210.5%
Net Debt
-$19.76M
Current Ratio
6.23
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology